Vivos Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Vivos Therapeutics, Inc. (VVOS) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-11.14-13.58-23.85-20.29-12.06
Depreciation & Amortization0.580.620.670.730.72
Stock Based Compensation0.761.843.112.662.66
Change in Working Capital-2.942.861.190.03-0.43
Change in Accounts Receivable-0.230.260.750.23-0.56
Change in Accounts Payable-1.050.730.490.14-0.27
Change in Other Working Capital0.012.49-0.16-0.010.41
Other Operating Activities0.01-3.692.37-0.013.43
Net Cash from Operating Activities-12.69-11.95-19.60-15.74-5.68
Investing Activities
Capital Expenditures-0.57-0.850.92-2.40-0.12
Acquisitions0.000.000.00-0.230.00
Other Investing Activities0.000.000.000.010.00
Net Cash from Investing Activities-0.57-0.85-0.92-2.61-0.12
Financing Activities
Debt Repayment0.000.000.00-0.03-0.32
Common Stock Issued7.8012.000.0027.9322.29
Common Stock Repurchased0.000.000.00-1.500.00
Other Financing Activities-1.36-1.080.00-2.24-0.25
Net Cash from Financing Activities17.8810.920.0024.1723.54
Summary
Net Change in Cash4.62-1.88-20.515.8217.74
Cash at Beginning of Period1.643.5224.0318.210.47
Cash at End of Period6.261.643.5224.0318.21
Free Cash Flow-13.26-12.80-20.52-18.13-5.80
Supplemental Disclosures
Interest Paid0.010.000.000.020.03